Last week the markets continued to push aside any bad news thrown in its path and continued its triumphant march higher. We saw the volatility index (VIX) spike during the week, before quickly returning to lower levels. With interest rates as low as they are, investors are still being forced to turn to... Read more
Posts Tagged ‘Bristol-Myers Squibb’
Elite Inside Trader Weekly Market Recap
March 28 | Posted by Kevin Monaghan | Inside Trader Highlights Tags: AFL, Aflac, American Express, AXP, Baidu, BIDU, BMY, Bristol-Myers Squibb, Capital One, COF, Discover Financial Services, Double Bullish US Dollar Index ETF, Euro, European Debt, Gold, JNJ, Johnson & Johnson, Micron Technology, MU, NG, NovaGold Resources, PFE, Pfizer, PLCN, Portugal, Priceline.com, Research In Motion, RIMM, Silver, SLV, US Dollar, UUP
These Stocks May Have Enough Steam Left For 2011
March 7 | Posted by Kevin Monaghan | Top Story Tags: BIP, BMY, Bristol-Myers Squibb, Brooksfield Infrastructure Partners, C, Citi, High Yield Stocks, INTC, Intel, JP Morgan Chase, JPM, Manulife, MFC, PRU, Prudential Financial, Shares, StocksThe recent stock market rally appears as if it may be running out of steam. Or is it? After spending most of the last 6 months in “overbought” territory, the economic recovery however still seems to be well underway. Unfortunately, there are enough headwinds in place to make investors feel a little worried... Read more
Are The Big Drug Companies Still Good Value?
December 13 | Posted by Kevin Monaghan | Top Story Tags: 2011 Outlook, BMY, Bristol-Myers Squibb, Crucell, CRXL, Drug Companies, GENZ, Genzme, Goldman Sachs, GS, JNJ, Johnson & Johnson, Legg Mason, LM, Merck, MRK, PFE, Pfizer, Pharmaceuticals, Sanofi-Aventis, SNY, Value, Value StocksThe Big Pharmaceutical companies have had a slow going year. Many of them are trading right where they started in 2010 or even lower. Although there have been winners such as Genzyme (GENZ), who received a bid from Sanofi-Aventis (SNY) and now trades near $70 after starting the year under $50, most of... Read more
3 Powerhouse Dividend Stocks For Your Portfolio
November 22 | Posted by Kevin Monaghan | Cash Flow Corner, Inside Trader Highlights Tags: Altria, AT&T, BMY, Bristol-Myers Squibb, Dividends, High Yield Stocks, Income, Income Stocks, JNJ, Johnson & Johnson, MO, Philip Morris, PM, Shares, Stocks, T, Verizon, VZDividends are one of my favorite parts of investing. There is nothing like seeing passive income flow into the cash portion of your brokerage account. Hold stocks over time, like Johnson & Johnson (JNJ), and you could see the dividends from your shares rise year after year. Build enough shares up over time,... Read more
